Metabolism and metabolic inhibition of gambogic acid in rat liver microsomes

被引:1
|
作者
Yi-tong LIU Kun HAO Xiao-quan LIU~2 Guang-ji WANG Key Lab of Drug Metabolism and Pharmacokinetics
机构
关键词
gambogic acid; metabolism; cytochrome P-450; liver microsomes; metabolic inhibition;
D O I
暂无
中图分类号
R96 [药理学];
学科分类号
100602 ; 100706 ;
摘要
Aim:To study the metabolism of gambogic acid(GA)and the effects of selectivecytochrome P-450(CYP450)inhibitors on the metabolism of GA in rat liver mi-crosomes in vitro.Methods:Rat liver microsomes were used to perform metabo-lism studies.Various selective CYP450 inhibitors were used to investigate theireffects on the metabolism of GA and the principal CYP450 isofonn involved in theformation of major metabolite M1in rat liver microsomes.Types of inhibition in anenzyme kinetics model were used to model the interaction.Results:GA wasrapidly metabolized to two phase I metabolites,M1and M2,in rat liver microsomes.Ml and M2were tentatively presumed to be the hydration metabolite and epoxidemetabolite of GA,respectively,α-Naphthoflavone uncompetitively inhibited theformation of M1while ketoconazole,sulfaphenazole,diethyl dithiocarbamate andquinidine had little or no inhibitory effects on the formation of M1.Conclusion:GA is rapidly metabolized in rat liver microsomes and M1is crucial for the elimina-tion of GA.Cytochrome P-450 1A2 is the major rat CYP involved in the metabolismof GA.
引用
收藏
页码:1253 / 1258
页数:6
相关论文
共 50 条
  • [41] The Disposition of Oxymatrine in the Vascularly Perfused Rat Intestine-Liver Preparation and Its Metabolism in Rat Liver Microsomes
    Huang, Li Hua
    Zhong, Yun Ming
    Xiong, Xiao Hong
    Cen, Mei Feng
    Cheng, Xuan Ge
    Wang, Gui Xiang
    Chen, Ji Sheng
    Wang, Su Jun
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 105 (02) : 897 - 903
  • [42] Evaluation of Metabolic Stability of Kinsenoside, an Antidiabetic Candidate, in Rat and Human Liver Microsomes
    Rehman, Shaheed Ur
    Kim, In Sook
    Choi, Min Sun
    Luo, Zengwei
    Yao, Guangming
    Xue, Yongbo
    Zhang, Yonghui
    Yoo, Hye Hyun
    MASS SPECTROMETRY LETTERS, 2015, 6 (02) : 48 - 51
  • [43] Metabolism of the carcinogen alpha-asarone in liver microsomes
    Cartus, Alexander T.
    Schrenk, Dieter
    FOOD AND CHEMICAL TOXICOLOGY, 2016, 87 : 103 - 112
  • [44] Metabolism of ginger component [6]-shogaol in liver microsomes from mouse, rat, dog, monkey, and human
    Chen, Huadong
    Soroka, Dominique
    Zhu, Yingdong
    Sang, Shengmin
    MOLECULAR NUTRITION & FOOD RESEARCH, 2013, 57 (05) : 865 - 876
  • [45] Effect of phenobarbital and spironolactone treatment on the oxidative metabolism of antipyrine by rat liver microsomes
    Szakács, T
    Veres, Z
    Vereczkey, L
    POLISH JOURNAL OF PHARMACOLOGY, 2001, 53 (01): : 11 - 19
  • [46] Inhibition of UDP-glucuronosyltransferases in rat liver microsomes by natural mutagens and carcinogens
    Grancharov, K
    Engelberg, H
    Naydenova, Z
    Müller, G
    Rettenmeier, AW
    Golovinsky, E
    ARCHIVES OF TOXICOLOGY, 2001, 75 (10) : 609 - 612
  • [47] The in vitro metabolism of GMDTC in liver microsomes of human, monkey, dog, rat and mouse: Metabolic stability assessment, metabolite identification and interspecies comparison
    Hu, Wei
    Zhong, Zhi-Yong
    Ren, Xue-Feng
    Liu, Hai-Yang
    Tang, Xiao-Jiang
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2023, 236
  • [48] Interspecies variability and drug interactions of loxapine metabolism in liver microsomes
    Bun, SS
    Voeurng, V
    Bun, H
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2003, 28 (04) : 295 - 300
  • [49] Interspecies variability and drug interactions of loxapine metabolism in liver microsomes
    Sok Siya Bun
    Vireak Voeurng
    Hot Bun
    European Journal of Drug Metabolism and Pharmacokinetics, 2003, 28 : 295 - 300
  • [50] Metabolism of aildenafil in vivo in rats and in vitro in mouse, rat, dog, and human liver microsomes
    Li, Yan
    Wu, Linan
    Gu, Yuan
    Si, Duanyun
    Liu, Changxiao
    DRUG TESTING AND ANALYSIS, 2014, 6 (06) : 552 - 562